Medication-induced arsenical keratosis is a rare type of arsenical keratosis. We describe here a case of 70-year-old man to explore the clinical characters, diagnosis and treatment of medication-induced arsenical keratosis in order to improve the understanding of this disease and reduce the misdiagnosis rate. The clinical characters, signs, lab findings as well as progression, diagnosis and treatment in the case of arsenical keratosis were analyzed. The patient of medication-induced arsenical keratosis suffered from chronic eczema. He has taken realgar during the treatment. His medication caused arsenical keratosis. Medication-induced arsenical keratosis is rare. Making the medication history clear and using urine arsenic detection if necessary are of significance to understand the patients' condition. It is quite effective that using Sodium Dimercaptosulphonate during the treatment without delay.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4358615PMC

Publication Analysis

Top Keywords

arsenical keratosis
32
medication-induced arsenical
16
arsenical
8
keratosis rare
8
clinical characters
8
diagnosis treatment
8
keratosis
7
keratosis caused
4
caused medication
4
medication case
4

Similar Publications

A comprehensive analysis of the impact of arsenic, fluoride, and nitrate-nitrite dynamics on groundwater quality and its health implications.

J Hazard Mater

January 2025

Third World Center (TWC) for Science and Technology, H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan. Electronic address:

Groundwater contamination is a growing global concern. The objective of the present study is to assess the groundwater quality of Khairpur district, Sindh, Pakistan-a region which is emblematic of broad environmental and public health challenges prevalent in South Asian countries. The study also aims to comprehend the impact of arsenic (As), fluoride (F), and nitrate (NO) dynamics and its health implications.

View Article and Find Full Text PDF

Dermatoscopic Radial Rippling of Pigment: A Potential Indicator of Pigmented Bowen's Disease.

Skinmed

October 2024

Empire Dermatology (Private Practice), Syracuse, NY.

Article Synopsis
  • - Pigmented Bowen's disease (pBD) is a rare form of Bowen's disease, making up only 1.67%-5.5% of lesions, and it can be mistaken for various skin conditions like actinic keratosis and melanoma.
  • - This skin condition usually appears as a flat or slightly raised, scaly, and well-defined plaque, mainly affecting individuals in their sixties and is generally asymptomatic.
  • - Key risk factors for developing pBD include HPV infection, exposure to arsenic and sunlight, ionizing radiation, and skin trauma.
View Article and Find Full Text PDF

Psoriasis complicated with arsenical keratosis and cutaneous squamous cell carcinoma: a case report.

Front Oncol

October 2024

Department of Oncology of Integrative Chinese and Western Medicine, National Center for Integrated Traditional Chinese and Western Medicine, China-Japan Friendship Hospital, Beijing, China.

Rare cases of arsenical keratosis are attributed to the ingestion of arsenic-containing traditional Chinese medicines for conditions such as psoriasis. Arsenic is a potent carcinogen, and squamous cell carcinoma is known to develop in arsenical keratosis. A 51-year-old male patient with a 30-year history of psoriasis and a history of arsenic poisoning presented with suppuration, ulceration, and pain one and a half years after trauma to the right thumb.

View Article and Find Full Text PDF
Article Synopsis
  • * This study seeks to create a noninvasive method for estimating arsenic exposure using AI, analyzing 9,988 photos of hands and feet from 2,497 subjects, correlating visual features with arsenic levels.
  • * The AI model achieved strong prediction accuracy with area under the curve (AUC) values of 0.813 for arsenic concentration and 0.779 for cumulative exposure, indicating promising potential for noninvasive assessment in future epidemiological research.
View Article and Find Full Text PDF

Effects of tauroursodeoxycholate on arsenic-induced hepatic injury in mice: A comparative transcriptomic analysis.

J Trace Elem Med Biol

December 2024

Center for Endemic Disease Control, Chinese Center for Disease Control and Prevention, Harbin Medical University, Harbin 150081, PR China; National Health Commission & Education Bureau of Heilongjiang Province, Key Laboratory of Etiology and Epidemiology, Harbin Medical University (23618504), Harbin 150081, PR China; Heilongjiang Provincial Key Laboratory of Trace Elements and Human Health, Harbin Medical University, Harbin 150081, PR China; Institute of Cell Biotechnology, China and Russia Medical Research Center, Harbin Medical University, Harbin 150081, PR China. Electronic address:

Article Synopsis
  • Prolonged arsenic exposure can harm various body systems, particularly the liver, causing symptoms like skin changes, gastrointestinal issues, and anemia, with TUDCA showing potential protective effects against liver injury.
  • A study was conducted on mice to investigate TUDCA's role in alleviating arsenic-induced liver damage, spanning over 24 weeks with two distinct phases of experiments.
  • Through RNA sequencing, researchers identified differentially expressed genes that may explain how TUDCA mitigates liver injury from arsenic, aiming to uncover useful insights for treatment.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!